ATP Dependent Efflux Transporters ABCB1 and ABCG2 Are Unlikely to Impact the Efficacy, or Mediate Resistance to the Tyrosine Kinase Inhibitor, Ponatinib

被引：0
|
作者：
White, Deborah L. [1 ]
Lu, Liu [1 ]
Clackson, Timothy P. [3 ]
Saunders, Verity A. [2 ]
Hughes, Timothy P. [4 ]
机构：
[1] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
[2] Ctr Canc Biol SA Pathol RAH Site, Dept Haematol, Adelaide, SA, Australia
[3] ARIAD Pharmaceut, Adelaide, SA, Australia
[4] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA, Australia
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1180 / 1180
页数：1
相关论文
共 50 条
  • [11] Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters
    Yun-Kai Zhang
    Guan-Nan Zhang
    Yi-Jun Wang
    Bhargav A. Patel
    Tanaji T. Talele
    Dong-Hua Yang
    Zhe-Sheng Chen
    Scientific Reports, 6
  • [12] What next? Preferably development of drugs that are no longer transported by the ABCB1 and ABCG2 efflux transporters
    van Hoppe, Stephanie
    Schinkel, Alfred H.
    PHARMACOLOGICAL RESEARCH, 2017, 123 : 144 - 144
  • [13] The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib
    Loos, Nancy H. C.
    Sparidans, Rolf W.
    Heydari, Paniz
    Bui, Viet
    Lebre, Maria C.
    Beijnen, Jos H.
    Schinkel, Alfred H.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 485
  • [14] Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells
    L Lu
    V A Saunders
    T M Leclercq
    T P Hughes
    D L White
    Leukemia, 2015, 29 : 1792 - 1794
  • [15] Ponatinib is not transported by ABCB1, ABCG2 or OCT-1 in CML cells
    Lu, L.
    Saunders, V. A.
    Leclercq, T. M.
    Hughes, T. P.
    White, D. L.
    LEUKEMIA, 2015, 29 (08) : 1792 - 1794
  • [16] Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2
    Lepper, ER
    Nooter, K
    Verweij, J
    Acharya, M
    Figg, WD
    Sparreboom, A
    PHARMACOGENOMICS, 2005, 6 (02) : 115 - 138
  • [17] Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications
    Sakurai, A
    Tamura, A
    Onishi, Y
    Ishikawa, T
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (14) : 2455 - 2473
  • [18] Poziotinib Inhibits the Efflux Activity of the ABCB1 and ABCG2 Transporters and the Expression of the ABCG2 Transporter Protein in Multidrug Resistant Colon Cancer Cells
    Zhang, Yongchao
    Wu, Zhuo-Xun
    Yang, Yuqi
    Wang, Jing-Quan
    Li, Jun
    Sun, Zoey
    Teng, Qiu-Xu
    Ashby, Charles R., Jr.
    Yang, Dong-Hua
    CANCERS, 2020, 12 (11) : 1 - 24
  • [19] Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function
    Atisha-Fregoso, Yemil
    Lima, Guadalupe
    Pascual-Ramos, Virginia
    Banos-Pelaez, Miguel
    Fragoso-Loyo, Hilda
    Jakez-Ocampo, Juan
    Contreras-Yanez, Irazu
    Llorente, Luis
    PLOS ONE, 2016, 11 (07):
  • [20] Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
    Strouse, J. Jacob
    Ivnitski-Steele, Irena
    Waller, Anna
    Young, Susan M.
    Perez, Dominique
    Evangelisti, Annette M.
    Ursu, Oleg
    Bologa, Cristian G.
    Carter, Mark B.
    Salas, Virginia M.
    Tegos, George
    Larson, Richard S.
    Oprea, Tudor I.
    Edwards, Bruce S.
    Sklar, Larry A.
    ANALYTICAL BIOCHEMISTRY, 2013, 437 (01) : 77 - 87
12345